These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 12057733

  • 1. Differential effect of gonadotropin-releasing hormone analogue treatment on estrogen levels and sulfatase activity in uterine leiomyoma and myometrium.
    van de Ven J, Donker TH, Blankenstein MA, Thijssen JH.
    Fertil Steril; 2002 Jun; 77(6):1227-32. PubMed ID: 12057733
    [Abstract] [Full Text] [Related]

  • 2. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
    Wang H, Wu X, Englund K, Masironi B, Eriksson H, Sahlin L.
    Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
    [Abstract] [Full Text] [Related]

  • 3. [Study on the local estrogen biosynthesis in human uterine leiomyoma].
    Urabe M, Yamamoto T, Naito K, Kitawaki J, Honjo H, Okada H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1229-36. PubMed ID: 2212823
    [Abstract] [Full Text] [Related]

  • 4. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.
    van de Ven J, Sprong M, Donker GH, Thijssen JH, Mak-Kregar S, Blankenstein MA.
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():61-8. PubMed ID: 12227888
    [Abstract] [Full Text] [Related]

  • 5. Effect of Decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium.
    Pasqualini JR, Cornier E, Grenier J, Vella C, Schatz B, Netter A.
    Fertil Steril; 1990 Jun; 53(6):1012-7. PubMed ID: 2140991
    [Abstract] [Full Text] [Related]

  • 6. Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium.
    Gentry CC, Okolo SO, Fong LF, Crow JC, Maclean AB, Perrett CW.
    Clin Sci (Lond); 2001 Dec; 101(6):691-5. PubMed ID: 11724658
    [Abstract] [Full Text] [Related]

  • 7. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
    Parsanezhad ME, Azmoon M, Alborzi S, Rajaeefard A, Zarei A, Kazerooni T, Frank V, Schmidt EH.
    Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
    [Abstract] [Full Text] [Related]

  • 8. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
    Yun BS, Seong SJ, Cha DH, Kim JY, Kim ML, Shim JY, Park JE.
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
    [Abstract] [Full Text] [Related]

  • 9. Effects of treatment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure.
    Bozzini N, Rodrigues CJ, Petti DA, Bevilacqua RG, Gonçalves SP, Pinotti JA.
    Acta Obstet Gynecol Scand; 2003 Apr; 82(4):330-4. PubMed ID: 12716317
    [Abstract] [Full Text] [Related]

  • 10. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
    Levens E, Luo X, Ding L, Williams RS, Chegini N.
    Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
    [Abstract] [Full Text] [Related]

  • 11. Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.
    De Falco M, Staibano S, D'Armiento FP, Mascolo M, Salvatore G, Busiello A, Carbone IF, Pollio F, Di Lieto A.
    J Soc Gynecol Investig; 2006 May; 13(4):297-303. PubMed ID: 16697947
    [Abstract] [Full Text] [Related]

  • 12. Expression of progesterone receptors A and B and insulin-like growth factor-I in human myometrium and fibroids after treatment with a gonadotropin-releasing hormone analogue.
    Wu X, Wang H, Englund K, Blanck A, Lindblom B, Sahlin L.
    Fertil Steril; 2002 Nov; 78(5):985-93. PubMed ID: 12413982
    [Abstract] [Full Text] [Related]

  • 13. GnRH agonist decreases endothelial nitric oxide synthase (eNOS) expression in leiomyoma.
    Gokdeniz R, Ozen S, Mizrak B, Bazoglu N.
    Int J Gynaecol Obstet; 2000 Sep; 70(3):347-52. PubMed ID: 10967169
    [Abstract] [Full Text] [Related]

  • 14. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
    Luo X, Levens E, Williams RS, Chegini N.
    Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
    [Abstract] [Full Text] [Related]

  • 15. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A, Vollenhoven B, Sowter M.
    Cochrane Database Syst Rev; 2001 Jun; (2):CD000547. PubMed ID: 11405968
    [Abstract] [Full Text] [Related]

  • 16. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA, Kettel LM, Morales AJ, Roberts VJ, Yen SS.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [Abstract] [Full Text] [Related]

  • 17. [Clinical trial on the effectiveness and safety of triptorelin in treatment of uterine leiomyoma].
    Zhou YF, Yang DZ, Hu LN, Zheng SR.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):460-3. PubMed ID: 16080872
    [Abstract] [Full Text] [Related]

  • 18. Two-step gonadotropin-releasing hormone agonist treatment of uterine leiomyomas: standard-dose therapy followed by reduced-dose therapy.
    Broekmans FJ, Hompes PG, Heitbrink MA, Netelenbos CC, Roos JC, Falke TM, Schoemaker J.
    Am J Obstet Gynecol; 1996 Nov; 175(5):1208-16. PubMed ID: 8942490
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone receptor messenger ribonucleic acid expression in leiomyoma and surrounding myometrium.
    Sharara FI, Nieman LK.
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):814-9. PubMed ID: 7573249
    [Abstract] [Full Text] [Related]

  • 20. Decreased expression of mac25 mRNA in uterine leiomyomata compared with adjacent myometrium.
    Kim JG, Kim MH, Kim IS, Moon SY, Kang SB, Lee HP, Lee JY.
    Am J Reprod Immunol; 2000 Jan; 43(1):53-7. PubMed ID: 10698042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.